Bacil Pharma Limited Overview
Valuation check: BACPHAR.BO's PEG ratio is -52.32, below the sector sector average of 10.05.
Get informed when a big investor buys or sells
+ Follow-52.32
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for BACPHAR.BO is -52.32. That is below the sector sector average of 10.05. Investors often review this figure alongside Bacil Pharma Limited's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, BACPHAR.BO currently prints -52.32 for PEG ratio, while the sector average sits near 10.05. That is roughly 620.4% below the sector mean. Large gaps often invite a closer look at Bacil Pharma Limited's growth, margins, and balance sheet.
A PEG ratio of -52.32 for Bacil Pharma Limited is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with BACPHAR.BO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting BACPHAR.BO's PEG ratio (-52.32), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
